Curevac logo

Curevac Share Price Today

(NASDAQ: CVAC)

Curevac share price is $3.4 & ₹287.72 as on 2 May 2025, 2.30 'hrs' IST

$3.4

-0.15

(-4.23%)

Market is closed - opens 7 PM, 02 May 2025

View live Curevac share price in Dollar and Rupees. Guide to invest in Curevac stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Curevac, along with analyst recommendations, forecasts, and comprehensive financials.

Curevac share price movements

  • Today's Low: $3.39
    Today's High: $3.57

    Day's Volatility :5.18%

  • 52 Weeks Low: $2.37
    52 Weeks High: $5.28

    52 Weeks Volatility :55.11%

Curevac (CVAC) Returns

PeriodCurevacSector (Health Care)Index (Russel 2000)
3 Months
-6.07%
-4.4%
0.0%
6 Months
28.99%
-5.0%
0.0%
1 Year
28.52%
-0.1%
0.0%
3 Years
-79.45%
8.4%
-6.1%

Curevac (CVAC) Key Statistics

in dollars & INR

Previous Close
$3.55
Open
$3.6
Today's High
$3.57
Today's Low
$3.385
Market Capitalization
$788.5M
Today's Volume
$627.7K
52 Week High
$5.28
52 Week Low
$2.37
Revenue TTM
$535.2M
EBITDA
$222.6M
Earnings Per Share (EPS)
$0.82
PE Ratio
4.23
Profit Margin
30.31%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
26.73%

How to invest in Curevac Stock (CVAC) from India?

It is very easy for Indian residents to invest directly in Curevac from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Curevac stock in both Indian Rupees (INR) and US Dollars (USD). Search for Curevac or CVAC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Curevac or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Curevac shares which would translate to 0.249 fractional shares of Curevac as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Curevac, in just a few clicks!

Returns in Curevac (CVAC) for Indian investors in Rupees

The Curevac stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Curevac investment value today

Current value as on today

₹1,24,161

Returns

₹24,161

(+24.16%)

Returns from Curevac Stock

₹22,744 (+22.74%)

Dollar Returns

₹1,417 (+1.42%)

Indian investors sentiment towards Curevac (CVAC)

-31%

Period: Apr 1, 2025 to May 1, 2025. Change in 30 Days versus previous period

Search interest for Curevac Stock from India on INDmoney has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Curevac

  • Millennium Management LLC

    0.73%

  • Bill & Melinda Gates Foundation

    0.70%

  • BlackRock Inc

    0.54%

  • UBS Group AG

    0.26%

  • Alyeska Investment Group, L.P.

    0.22%

  • Point72 Asset Management, L.P.

    0.20%

Analyst Recommendation on Curevac

Rating
Trend

Buy

    66%Buy

    26%Hold

    6%Sell

Based on 15 Wall street analysts offering stock ratings for Curevac(by analysts ranked 0 to 5 stars)

Analyst Forecast on Curevac Stock (CVAC)

What analysts predicted

Upside of 91.8%

Target:

$6.52

Current:

$3.40

Insights on Curevac Stock (Ticker Symbol: CVAC)

  • Price Movement

    In the last 7 days, CVAC stock has moved up by 10.2%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 493.90M → 14.46M (in $), with an average decrease of 48.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 338.04M → -32.76M (in $), with an average decrease of 54.9% per quarter
  • CVAC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.1% return, outperforming this stock by 46.6%
  • CVAC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 89.3% return, outperforming this stock by 168.6%
  • Price to Sales

    ForCVAC every $1 of sales, investors are willing to pay $1.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Curevac Technicals Summary

Sell

Neutral

Buy

Curevac is currently in a neutral trading position according to technical analysis indicators.

Curevac (CVAC) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Curevac logo
24.48%
28.99%
28.52%
-79.45%
-93.63%
Biontech Se logo
9.85%
-8.05%
11.13%
-31.31%
123.92%
Regeneron Pharmaceuticals, Inc. logo
-4.3%
-29.03%
-36.14%
-9.35%
10.5%
Vertex Pharmaceuticals Incorporated logo
5.32%
8.08%
27.25%
89.22%
92.38%
Alnylam Pharmaceuticals, Inc. logo
-1.34%
-3.89%
75.14%
84.24%
92.68%

About Curevac

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company's portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In addition, the company offers The RNA Printer, a downsized, integrated, and highly automated process for manufacturing of mRNA vaccines and therapeutics. Further, it develops prophylactic vaccine lead candidate that addresses urinary tract infections targeting uropathogenic E. coli (UPEC) bacteria; vaccine candidates CV0601 and CV0701, which are in phase 2 clinical study against SARS-CoV-2; vaccines for off-the-shelf and fully personalized cancer precision immunotherapies in oncology; and CVGBM for treating cancer. Additionally, the company develops, manufactures, and commercializes mRNA vaccines targeting SARS-CoV-2 variants; antigen cancer precision immunotherapy candidate that targets squamous non-small cell lung cancer; and antigen cancer precision immunotherapy candidate CVGBM that is tested in patients with surgically resected MGMT-unmethylated glioblastoma or astrocytoma with a molecular signature of glioblastoma. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.
Organization
Curevac
Employees
825
CEO
Dr. Alexander Zehnder M.B.A., M.D.
Industry
Health Technology

Management People of Curevac

NameTitle
Dr. Alexander Zehnder M.B.A., M.D.
CEO, MD & Member of Management Board
Mr. Axel-Sven Malkomes
CFO & Member of Executive Board
Dr. Malte Greune Ph.D.
COO, Member of Management Board & MD
Dr. Myriam Mendila M.D.
Chief Scientific Officer, Head of R&D, MD & Member of the Management Board
Mr. Thaminda Ramanayake
Chief Business Officer & Member of Executive Board
Dr. Sarah Fakih
Vice President Corporate Communications & Investor Relations
Mr. Marco Rau L.L.M., Ph.D.
General Counsel
Slavica Stevanovic-Heck
Head of Human Resources
Dr. Ulrike Gnad-Vogt M.D., Ph.D.
Senior VP & Area Head of Oncology
Dr. Patrick Baumhof
Senior Vice President of Technology

Important FAQs about investing in CVAC Stock from India :

What is Curevac share price today?

Curevac share price today stands at $3.40, Open: $3.60 ; Previous Close: $3.55 ; High: $3.57 ; Low: $3.39 ; 52 Week High: $5.28 ; 52 Week Low: $2.37.

The stock opens at $3.60, after a previous close of $3.55. The stock reached a daily high of $3.57 and a low of $3.39, with a 52-week high of $5.28 and a 52-week low of $2.37.

Can Indians buy Curevac shares?

Yes, Indians can invest in the Curevac (CVAC) from India.

With INDmoney, you can buy Curevac at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Curevac at zero transaction cost.

How can I buy Curevac shares from India?

It is very easy to buy Curevac from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Curevac (CVAC) be purchased?

Yes, you can buy fractional shares of Curevac with INDmoney app.

What are the documents required to start investing in Curevac stocks?

To start investing in Curevac, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Curevac Stock (CVAC)?

Today’s highest price of Curevac (CVAC) is $3.57.

Today’s lowest price of Curevac (CVAC) is $3.39.

What is today's market capitalisation of Curevac?

Today's market capitalisation of Curevac CVAC is 788.5M

What is the 52 Week High and Low Range of Curevac Stock (CVAC)?

  • 52 Week High

    $5.28

  • 52 Week Low

    $2.37

What are the historical returns of Curevac (CVAC)?

  • 1 Month Returns

    24.48%

  • 3 Months Returns

    28.99%

  • 1 Year Returns

    28.52%

  • 5 Years Returns

    -93.63%

Who is the Chief Executive Officer (CEO) of Curevac ?

Dr. Alexander Zehnder M.B.A., M.D. is the current Chief Executive Officer (CEO) of Curevac.